Bank of America Corporation reissued their buy rating on shares of Catalent Inc (NASDAQ:CTLT) in a report published on Tuesday. The brokerage currently has a $40.00 price target on the stock, up from their prior price target of $38.00.

CTLT has been the subject of several other research reports. BidaskClub raised Catalent from a sell rating to a hold rating in a research note on Wednesday, August 16th. Zacks Investment Research raised Catalent from a sell rating to a buy rating and set a $39.00 price target for the company in a research note on Tuesday, July 4th. Piper Jaffray Companies reissued an overweight rating and issued a $45.00 price target on shares of Catalent in a research note on Tuesday. Jefferies Group LLC reissued a hold rating and issued a $38.00 price target (up previously from $35.00) on shares of Catalent in a research note on Tuesday. Finally, William Blair raised Catalent from a market perform rating to an outperform rating in a research note on Monday, May 15th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average price target of $35.88.

Shares of Catalent (CTLT) opened at 40.27 on Tuesday. The firm has a market capitalization of $5.03 billion and a P/E ratio of 47.43. The firm has a 50-day moving average of $35.14 and a 200-day moving average of $32.37. Catalent has a one year low of $21.83 and a one year high of $41.37.

Catalent (NASDAQ:CTLT) last issued its quarterly earnings results on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.08. The company had revenue of $616.90 million during the quarter, compared to analysts’ expectations of $547.48 million. Catalent had a return on equity of 16.95% and a net margin of 4.88%. The business’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.52 earnings per share. On average, equities analysts predict that Catalent will post $1.60 earnings per share for the current fiscal year.

WARNING: “Catalent Inc (CTLT) Receives “Buy” Rating from Bank of America Corporation” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/08/30/catalent-inc-ctlt-receives-buy-rating-from-bank-of-america-corporation.html.

In related news, SVP Christine Dolan sold 745 shares of the company’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total transaction of $25,963.25. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Several large investors have recently made changes to their positions in the stock. Flinton Capital Management LLC raised its stake in shares of Catalent by 17.7% in the first quarter. Flinton Capital Management LLC now owns 3,616 shares of the company’s stock valued at $102,000 after buying an additional 544 shares during the last quarter. Acrospire Investment Management LLC raised its stake in shares of Catalent by 72.2% in the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after buying an additional 1,300 shares during the last quarter. Quantbot Technologies LP raised its stake in shares of Catalent by 110.7% in the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock valued at $120,000 after buying an additional 1,804 shares during the last quarter. Meadow Creek Investment Management LLC raised its stake in shares of Catalent by 17.7% in the first quarter. Meadow Creek Investment Management LLC now owns 4,972 shares of the company’s stock valued at $141,000 after buying an additional 748 shares during the last quarter. Finally, Acadian Asset Management LLC raised its stake in shares of Catalent by 115.7% in the first quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock valued at $166,000 after buying an additional 3,136 shares during the last quarter.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Stock Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related stocks with our FREE daily email newsletter.